Edit search
Adalimumab and methotrextrate combination therapy in patient…
Adalimumab and methotrextrate combination therapy in patients with early RA sustains clinical remission and response through 5 years of adalimumab treatment.
Adalimumab and methotrextrate combination therapy in patients with early RA sustains clinical remission and response through 5 years of adalimumab treatment.
Article, Chapter
Authors: A. Pangan
Publication: Volume:48, Issue:2, Page(s):119-119
Published: 2009
Browse related articles
  Request a copy of this item
Cite this item